Expiry
-
{
- All
- News
- Videos
- Photos
- Web Stories
-
UP Makes Display Of 'Use By Date' Mandatory For All Sweets
Inspections carried out at sweet manufacturing and retail outlets have revealed that, in many instances, consumers are not provided with clear information regarding the date of manufacture and the expiry date of the sweets.
-
Tukaram Mundhe Calls Altered Expiry Dates And Nutrition Labels A 'Breach Of Public Trust'
Maharashtra FDA raided a Navi Mumbai warehouse altering expiry and nutrition labels on export food products from major brands.
-
Discard Your Eye Drops Within 30 Days Of Opening: Doctor Reveals The Truth About Expiry Dates
It is often recommended to discard a multi-dose eye drop bottle within 28 to 30 days of opening primarily because breaking the sterile seal exposes the liquid to air and physical contact.
-
Techie Fired By Meta To Return To India After 14 Years: 'Last Couple Weeks Have Been Gut-Wrenching'
A techie shared the gut-wrenching experience of Meta layoffs and how he was forced to return to India after 14 years.
-
Maharashtra Food Authority Busts Expired Food Racket, Seizes Rs 52 Lakh Stock
Maharashtra FDA busted a racket recycling expired food worth over Rs 52 lakh in Bhiwandi, seizing large quantities of illegal stock.
-
Watch: Video Shows How Expiry Dates Can Be Wiped Off Beverage Cans, Sparking Safety Concerns
A woman can be seen erasing the expiry date with sanitiser and tissue.
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Ozempic's Key Molecule To Go Off-Patent: What Changes Now?
Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.
-
UP Makes Display Of 'Use By Date' Mandatory For All Sweets
Inspections carried out at sweet manufacturing and retail outlets have revealed that, in many instances, consumers are not provided with clear information regarding the date of manufacture and the expiry date of the sweets.
-
Tukaram Mundhe Calls Altered Expiry Dates And Nutrition Labels A 'Breach Of Public Trust'
Maharashtra FDA raided a Navi Mumbai warehouse altering expiry and nutrition labels on export food products from major brands.
-
Discard Your Eye Drops Within 30 Days Of Opening: Doctor Reveals The Truth About Expiry Dates
It is often recommended to discard a multi-dose eye drop bottle within 28 to 30 days of opening primarily because breaking the sterile seal exposes the liquid to air and physical contact.
-
Techie Fired By Meta To Return To India After 14 Years: 'Last Couple Weeks Have Been Gut-Wrenching'
A techie shared the gut-wrenching experience of Meta layoffs and how he was forced to return to India after 14 years.
-
Maharashtra Food Authority Busts Expired Food Racket, Seizes Rs 52 Lakh Stock
Maharashtra FDA busted a racket recycling expired food worth over Rs 52 lakh in Bhiwandi, seizing large quantities of illegal stock.
-
Watch: Video Shows How Expiry Dates Can Be Wiped Off Beverage Cans, Sparking Safety Concerns
A woman can be seen erasing the expiry date with sanitiser and tissue.
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
GLP-1 Drugs In India: How To Spot Fakes Before It's Too Late
Counterfeit GLP-1 drugs like semaglutide are rising in India amid growing demand and multiple cheaper versions entering the market.
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Ozempic's Key Molecule To Go Off-Patent: What Changes Now?
Patent protections on semaglutide, developed by Novo Nordisk, will lapse on March 20, opening the door for domestic pharmaceutical companies to manufacture and sell their own versions of the drug.
